Casopitant: a novel NK1-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
Christina Ruhlmann, Jørn HerrstedtOdense University Hospital, Department of Oncology, Odense, DenmarkAbstract: Chemotherapy-induced nausea and vomiting (CINV) are among the most feared and distressing symptoms experienced by patients with cancer. The knowledge of the pathogenesis and neur...
Saved in:
Main Authors: | Christina Ruhlmann (Author), Jørn Herrstedt (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
by: Tito Borner, et al.
Published: (2023) -
NK1 receptor antagonists versus other antiemetics in the prevention of postoperative nausea and vomiting following laparoscopic surgical procedures: a systematic review and meta-analysis
by: John Cavaye, et al.
Published: (2022) -
Impact of 5-HT<sub>3</sub> receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study
by: Lin Swu-Jane, et al.
Published: (2012) -
Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting
by: Prasan R Bhandari
Published: (2012) -
Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting.
by: Prasan R Bhandari
Published: (2012)